Disclaimer: This information is for educational purposes only and should not be considered medical advice. Clinical decisions must always be made by a qualified healthcare professional based on the individual patient's condition, circumstances, and current evidence-based guidelines. This content is not a substitute for professional medical judgment.

---

Tonsillitis And Tonsillectomy

Overview

• Definition: Tonsillitis is an inflammation of the tonsils, which are two lymphoid tissue masses located at the back of the throat. It can be caused by viral or bacterial infections, most commonly Group A Streptococcus (GAS).
• Epidemiology: Tonsillitis is a very common condition, especially in children and adolescents.
  • Age: Peak incidence occurs in school-aged children (5-15 years old) for bacterial tonsillitis, while viral tonsillitis is common in younger children.
  • Transmission: Spreads person-to-person via respiratory droplets.
• Classification:
  • Acute Tonsillitis: Sudden onset of symptoms lasting typically 7-10 days.
    • Viral: Most common cause (50-80% of cases). Caused by adenoviruses, rhinovirus, influenza virus, parainfluenza virus, Epstein-Barr virus (EBV), enterovirus, herpes simplex virus (HSV).
    • Bacterial: Primarily caused by Group A Streptococcus (GAS) (Streptococcus pyogenes), responsible for 15-30% of pharyngitis in children and 5-15% in adults. Less common bacterial causes include Arcanobacterium haemolyticum, Mycoplasma pneumoniae, Chlamydia pneumoniae, and Fusobacterium necrophorum.
  • Recurrent Tonsillitis: Multiple episodes of acute tonsillitis within a defined period (e.g., meeting Paradise criteria).
  • Chronic Tonsillitis: Persistent inflammation of the tonsils, often with cryptic debris (tonsilloliths), chronic sore throat, and halitosis. Less clearly defined in guidelines.
  • Peritonsillar Abscess (Quinsy): A localized collection of pus between the tonsillar capsule and the superior constrictor muscle. A serious complication of acute tonsillitis.

Pathophysiology

• Mechanism:
  • Infection: Pathogens (viruses or bacteria) gain entry to the tonsillar crypts, proliferate, and induce an inflammatory response.
  • Immune Response: The tonsils, being part of Waldeyer's ring (lymphoid tissue), mount an immune response, leading to vasodilation, edema, erythema, and exudate formation.
  • Symptom Generation: Inflammation and swelling of the tonsils and surrounding pharyngeal tissue cause local pain, dysphagia, and fever.
• Risk Factors:
  • Age: School-aged children are at higher risk due to increased exposure and developing immune systems.
  • Close Contact: Living or working in close proximity to others (e.g., schools, daycare, military barracks).
  • Immunocompromise: Conditions that weaken the immune system can increase susceptibility.
  • Frequent Viral Infections: Can predispose to secondary bacterial infections.
• Protective Factors:
  • Intact Immune System: Healthy immune function helps clear infections.
  • Good Hygiene: Handwashing, avoiding close contact with sick individuals.
  • Vaccinations: Though not directly for tonsillitis, vaccinations for common viral illnesses (e.g., influenza, measles) can reduce overall respiratory tract infections.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Sore Throat: Often sudden onset, moderate to severe, with pain radiating to the ears.
  • Dysphagia/Odynophagia: Pain or difficulty swallowing.
  • Fever: Common, especially with bacterial infections (typically >100.4°F or 38°C).
  • Headache: Common.
  • Malaise/Fatigue: Generalized discomfort.
• Early Signs:
  • Mild sore throat.
  • Feeling of scratchiness in the throat.
  • Mild fever or feeling "unwell."
• Advanced Signs:
  • Voice Changes: "Hot potato" or muffled voice (suggests peritonsillar abscess).
  • Drooling/Inability to Swallow Saliva: Severe odynophagia, may indicate impending airway obstruction or peritonsillar abscess.
  • Trismus: Difficulty opening the mouth (common with peritonsillar abscess).
  • Unilateral Swelling: Indicative of peritonsillar abscess.
  • Neck Stiffness: May indicate deeper neck space infection.
• Atypical Presentations:
  • Scarlet Fever: GAS pharyngitis with a diffuse erythematous rash.
  • Mononucleosis (EBV): Can present with severe exudative tonsillitis, prolonged fever, significant fatigue, generalized lymphadenopathy, and splenomegaly. May be indistinguishable from bacterial tonsillitis without testing.
  • Gonococcal Pharyngitis: May be asymptomatic or present as mild pharyngitis.

Physical Examination

• Inspection:
  • Tonsillar Hyperemia and Edema: Red, swollen tonsils.
  • Tonsillar Exudates: White or yellow patches or streaks on the tonsil surface (can be present in both viral and bacterial, but more common/prominent in bacterial, especially GAS and EBV).
  • Uvula Deviation: Displacement of the uvula to the contralateral side suggests a peritonsillar abscess.
  • Palatal Petechiae: Small red spots on the soft palate, highly suggestive of GAS pharyngitis.
  • Scarlatiniform Rash: Fine, sandpaper-like rash (suggests scarlet fever due to GAS).
• Palpation:
  • Cervical Lymphadenopathy: Tender, enlarged anterior cervical lymph nodes are common in bacterial tonsillitis.
• Special Tests:
  • No specific "special tests" in the typical sense for tonsillitis diagnosis beyond visual inspection and palpation for lymphadenopathy. Focus is on differentiating viral from bacterial.

Diagnostic Approach

History Taking

• Key Questions:
  • Onset and Duration: When did symptoms start? How long have they lasted?
  • Fever: Presence, degree, and pattern.
  • Cough/Coryza/Hoarseness: Absence of these symptoms increases the likelihood of bacterial (GAS) infection. Their presence points more towards viral.
  • Exudates: Have you noticed white spots on your tonsils?
  • Exposure: Any contact with individuals with strep throat?
  • Past History: Previous episodes of tonsillitis, history of rheumatic fever.
  • Dysphagia/Drooling/Voice Change/Trismus: Questions to screen for peritonsillar abscess.
  • Centor/McIsaac Criteria Assessment: Quantifies risk of GAS.
    • Tonsillar exudates: +1 point
    • Swollen, tender anterior cervical lymph nodes: +1 point
    • Absence of cough: +1 point
    • History of fever (or oral temperature ≥100.4°F/38°C): +1 point
    • Age 3-14 years: +1 point
    • Age 15-44 years: 0 points
    • Age ≥45 years: -1 point
• Red Flags:
  • Severe difficulty swallowing or breathing: Potential airway compromise.
  • Drooling/inability to manage secretions: Sign of severe odynophagia or airway issue.
  • Trismus: Strong indicator of peritonsillar abscess.
  • Unilateral tonsillar swelling/uvula deviation: Suggests peritonsillar abscess.
  • Signs of dehydration: Due to inability to swallow fluids.
  • Systemic toxicity: Lethargy, poor perfusion, altered mental status.

Laboratory Tests

• First-Line:
  • Rapid Antigen Detection Test (RADT): Recommended for diagnosis of GAS pharyngitis in patients meeting Centor/McIsaac criteria. High specificity (~95-99%) but variable sensitivity (~70-90%). A positive RADT in a symptomatic patient is sufficient for diagnosis and treatment.
  • Throat Culture: Considered the gold standard for diagnosing GAS pharyngitis due to higher sensitivity (>90%).
    • Adults: If RADT is negative, a throat culture is generally not recommended in adults due to the low incidence of rheumatic fever.
    • Children (3-15 years): A negative RADT should be followed by a throat culture to rule out GAS, given the higher risk of rheumatic fever.
• Confirmatory:
  • Throat Culture: Confirms GAS when RADT is negative (in pediatric population).
• Monitoring:
  • Not routinely needed for acute tonsillitis once treatment is initiated.
  • ASO Titer/Anti-DNase B: May be used retrospectively to confirm prior GAS infection if there's suspicion of post-streptococcal sequelae (e.g., rheumatic fever, glomerulonephritis). Not used for acute diagnosis.
  • Monospot Test/EBV Serology: If infectious mononucleosis is suspected (e.g., prolonged fever, profound fatigue, generalized lymphadenopathy, splenomegaly, atypical lymphocytes on CBC).

Imaging

• Recommended:
  • Imaging is generally not recommended for uncomplicated tonsillitis.
• Advanced:
  • CT Scan with IV Contrast: Recommended if there is suspicion of a deep neck space infection, peritonsillar abscess (especially if aspiration/drainage is difficult or unsuccessful, or if other signs of deeper infection are present), parapharyngeal abscess, or retropharyngeal abscess. This helps delineate the extent of the infection and guide drainage.
  • Ultrasound: Can be used by experienced operators to differentiate cellulitis from abscess in the peritonsillar region, guiding needle aspiration.

Management

Acute Management

• Immediate:
  • Symptomatic Relief: Analgesics and antipyretics (acetaminophen, ibuprofen) for pain and fever. Warm saline gargles, lozenges, and throat sprays can provide local relief.
  • Hydration: Encourage fluid intake, especially if febrile or having difficulty swallowing.
• Stabilization:
  • Antibiotics for Bacterial Tonsillitis (GAS): Initiate appropriate antibiotic therapy promptly once GAS is confirmed or highly suspected.
    • Penicillin V: First-line.
      • Adults: 500 mg orally 2-3 times daily for 10 days.
      • Children: 25-50 mg/kg/day orally in 2-3 divided doses (max 1000 mg/day) for 10 days.
    • Amoxicillin: Often preferred in children due to taste and once-daily dosing potential.
      • Adults: 500 mg orally 2-3 times daily for 10 days.
      • Children: 50 mg/kg once daily or 25 mg/kg twice daily (max 1000 mg/day) for 10 days.
    • Benzathine Penicillin G (IM): Single injection for poor compliance.
      • Adults: 1.2 million units IM once.
      • Children (<60 lbs): 600,000 units IM once.
      • Children (≥60 lbs): 1.2 million units IM once.
    • For Penicillin Allergy (non-anaphylactic):
      • Cephalexin: 25-50 mg/kg/day orally divided BID for 10 days (max 1000 mg/day for children, 2000 mg/day for adults).
      • Cefadroxil: 30 mg/kg/day orally once daily for 10 days (max 1000 mg/day).
    • For Penicillin Allergy (anaphylactic):
      • Azithromycin: 12 mg/kg orally once daily for 5 days (max 500 mg/day). Or 500 mg on day 1, then 250 mg on days 2-5.
      • Clindamycin: 20-30 mg/kg/day orally divided TID for 10 days (max 1800 mg/day).
      • Clarithromycin: 15 mg/kg/day orally divided BID for 10 days (max 500 mg/day).
  • Peritonsillar Abscess Management:
    • Drainage: Needle aspiration or incision and drainage (I&D) is the mainstay.
    • Antibiotics: IV antibiotics are usually initiated (e.g., Ampicillin-sulbactam, Clindamycin). Transition to oral once stable.
• Emergency:
  • Airway Management: If airway obstruction is present or imminent due to severe tonsillar swelling or abscess, emergency intubation or tracheostomy may be required.
  • Sepsis Management: If signs of systemic infection or sepsis develop, aggressive fluid resuscitation, broad-spectrum IV antibiotics, and vasopressors if needed.

Chronic Management

• Pharmacological:
  • Chronic Tonsillitis: Antibiotics are generally not recommended for chronic tonsillitis unless acute exacerbations occur.
• Non-pharmacological:
  • Recurrent Tonsillitis: Non-surgical management includes symptomatic treatment of acute episodes.
  • Chronic Tonsillitis: Saline gargles, maintaining good oral hygiene, managing tonsilloliths.
• Monitoring:
  • Monitor for frequency and severity of recurrent episodes.
  • Monitor for complications such as peritonsillar abscess.

Treatment Algorithms

• First-Line (Acute Tonsillitis):
  1. Assess Clinical Likelihood of GAS: Use Centor/McIsaac score.
  2. Test for GAS: RADT (and throat culture for negative RADT in children).
  3. Positive GAS:
     • Penicillin V or Amoxicillin for 10 days.
     • Symptomatic relief (analgesics, antipyretics).
  4. Negative GAS (and culture if applicable):
     • No antibiotics (viral etiology assumed).
     • Symptomatic relief.
• Second-Line (Recurrent Tonsillitis):
  1. Review Indications for Tonsillectomy:
     • Paradise Criteria (Modified):
       • ≥7 documented episodes of tonsillitis in the preceding year, OR
       • ≥5 episodes/year in the preceding 2 years, OR
       • ≥3 episodes/year in the preceding 3 years.
     • Episodes must be well-documented (e.g., by a physician, with fever ≥101°F/38.3°C, cervical lymphadenopathy, tonsillar exudates, or positive GAS test).
  2. Consider Tonsillectomy: If criteria met and shared decision-making with patient/parents supports surgery.
• Refractory Cases:
  • Peritonsillar Abscess (PTA):
    • Aspiration/I&D: Primary treatment.
    • IV Antibiotics: Initial, then oral.
    • Immediate Tonsillectomy (Quinsy Tonsillectomy): May be considered if severe infection, recurrent PTA, or difficult drainage.
  • Chronic Tonsillitis with Significant Morbidity: Tonsillectomy may be considered in cases of chronic, debilitating sore throat, tonsilloliths, or halitosis refractory to conservative measures, though evidence base is less robust than for recurrent acute tonsillitis.
  • Airway Obstruction:
    • Tonsillectomy: For obstructive sleep apnea (OSA) due to tonsillar hypertrophy, especially in children.
    • Emergency Airway Management: If acute severe obstruction.

Complications

• Common:
  • Dehydration: Due to painful swallowing.
  • Spread of Infection: To adjacent tissues (e.g., cellulitis).
• Serious:
  • Peritonsillar Abscess: Most common deep neck infection complication.
  • Deep Neck Space Infections: Parapharyngeal, retropharyngeal abscesses (rare but life-threatening).
  • Post-Streptococcal Sequelae:
    • Acute Rheumatic Fever (ARF): Inflammatory disease affecting the heart (rheumatic heart disease), joints, brain, and skin. Preventable with prompt antibiotic treatment of GAS pharyngitis.
    • Post-streptococcal Glomerulonephritis (PSGN): Kidney inflammation. Not preventable by antibiotics once infection established, but antibiotics reduce transmission.
  • Airway Obstruction: Due to severe tonsillar hypertrophy or abscess.
  • Sepsis: Systemic inflammatory response to severe infection.
• Long-term:
  • Chronic Tonsillitis: Persistent inflammation, tonsilloliths.
  • Chronic Airway Obstruction: Due to persistent tonsillar hypertrophy, potentially leading to obstructive sleep apnea, growth disturbances, and behavioral issues in children.
  • Recurrent Episodes: Continual episodes impacting quality of life.

Prognosis

• Factors:
  • Etiology: Viral tonsillitis is self-limiting. Bacterial tonsillitis resolves well with antibiotics.
  • Prompt Treatment: Timely antibiotics for GAS prevent complications like ARF.
  • Underlying Health: Immunocompromised individuals may have more severe or prolonged courses.
• Survival: Excellent for uncomplicated tonsillitis. Mortality is rare, typically associated with severe, undiagnosed deep neck space infections or uncontrolled sepsis.
• Quality of Life:
  • Acute tonsillitis significantly impairs quality of life during the episode (pain, fever, inability to eat/drink).
  • Recurrent tonsillitis can lead to missed school/work, sleep disturbances, and overall diminished quality of life, which is a primary indication for tonsillectomy.
  • Tonsillectomy generally improves quality of life for those with appropriate indications, significantly reducing the frequency and severity of throat infections.

Prevention

• Primary:
  • Hand Hygiene: Frequent and thorough handwashing, especially after coughing/sneezing and before eating.
  • Avoid Close Contact: Limit exposure to individuals with active infections.
  • Respiratory Etiquette: Cover coughs and sneezes.
• Secondary:
  • Early Diagnosis and Treatment: Prompt identification and antibiotic treatment of GAS pharyngitis to prevent ARF and reduce spread.
• Tertiary:
  • Prophylactic Antibiotics (for ARF): Long-term penicillin prophylaxis is crucial for individuals with a history of acute rheumatic fever to prevent recurrent attacks and progressive heart valve damage.
  • Tonsillectomy: For appropriately selected patients with recurrent tonsillitis, to reduce the frequency and severity of episodes.

Special Populations

• Pediatric:
  • Most Common Age Group: Bacterial tonsillitis peaks in 5-15 year olds.
  • Higher Risk of ARF: Emphasizes the importance of GAS testing and antibiotic treatment.
  • Obstructive Sleep Apnea (OSA): Tonsillar hypertrophy is a leading cause of OSA in children, often a primary indication for tonsillectomy.
  • Antibiotic Dosing: Weight-based dosing is crucial.
  • Compliance: Parental education on completing the full course of antibiotics is vital.
• Geriatric:
  • Less common, but can occur.
  • Less likely to have GAS and more likely to have viral or other bacterial pathogens.
  • May have atypical presentations or less pronounced symptoms.
  • Comorbidities and polypharmacy must be considered when prescribing antibiotics and analgesics.
• Pregnancy:
  • Antibiotic Choice: Penicillins (Amoxicillin, Penicillin V) are safe and first-line. Macrolides (Azithromycin) are generally considered safe. Avoid tetracyclines and fluoroquinolones.
  • Fever Management: Acetaminophen is preferred. NSAIDs should be avoided in the third trimester.
  • Peritonsillar Abscess: Management is similar, but imaging may be modified (e.g., ultrasound preferred over CT if possible, or lead shielding with CT).
• Comorbidities:
  • Immunocompromised: May have more severe or prolonged infections. Careful selection of antibiotics, longer courses, and potentially hospital admission may be required. May have unusual pathogens.
  • Diabetes: Increased risk of more severe infections. Careful blood glucose monitoring.
  • Cardiac Disease: Patients with prosthetic valves or a history of endocarditis may require prophylactic antibiotics for tonsillectomy to prevent bacterial endocarditis, though the evidence for this is debated.

Clinical Pearls

• Diagnostic:
  • Centor/McIsaac Score is a guide, not a diagnostic tool: It helps stratify risk for GAS and guide testing, but definitive diagnosis relies on RADT/culture.
  • Viral symptoms are key: The presence of cough, runny nose, hoarseness, and conjunctivitis strongly suggests a viral etiology, even with some tonsillar exudates.
  • Mononucleosis mimic: Always consider EBV in adolescents/young adults with prolonged fatigue, generalized lymphadenopathy, and significant exudative tonsillitis, especially if antibiotics fail.
  • Palatal petechiae: A strong visual clue for GAS.
• Treatment:
  • 10-day course is critical for GAS: Shorter courses (e.g., 5-day azithromycin) are effective for eradication but may have slightly higher failure rates. Emphasize compliance to prevent rheumatic fever.
  • Don't forget symptomatic care: Even with antibiotics, pain and fever management are crucial for patient comfort and hydration.
  • Peritonsillar abscess = urgent drainage: Do not delay aspiration or I&D if suspected.
  • No "strep carrier" treatment: Do not treat asymptomatic GAS carriers, as they are not at risk for rheumatic fever and antibiotics contribute to resistance.
• Pitfalls:
  • Over-prescribing antibiotics for viral tonsillitis: Contributes to antibiotic resistance and patient side effects.
  • Failing to test for GAS: Especially in children, this risks missing treatable bacterial infection and preventable rheumatic fever.
  • Missing peritonsillar abscess: Failure to recognize red flags like trismus, muffled voice, and uvular deviation can delay critical intervention.
  • Inadequate antibiotic duration for GAS: Stopping antibiotics early increases the risk of rheumatic fever and recurrence.
  • Ignoring tonsillectomy indications: Delaying surgery when criteria are met can lead to significant morbidity and impact quality of life due to recurrent infections.

Recent Updates

• Guidelines:
  • Infectious Diseases Society of America (IDSA) Guidelines (2012): Remain a cornerstone for diagnosis and management of Group A Streptococcal Pharyngitis. Emphasize testing and appropriate antibiotic use.
  • American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) Clinical Practice Guideline: Tonsillectomy in Children (2019 Update): Reaffirms the Paradise criteria for recurrent tonsillitis as the primary indication for tonsillectomy and provides guidance on shared decision-making, preoperative evaluation, and management of pain/bleeding.
• Evidence:
  • Ongoing research refines understanding of the tonsillar microbiome and its role in chronic tonsillitis and recurrent infections, but does not yet impact routine clinical management significantly.
  • Increasing focus on the non-infectious indications for tonsillectomy, primarily obstructive sleep apnea (OSA), with studies consistently showing improvement in pediatric OSA post-tonsillectomy.
• Controversies:
  • Role of imaging in peritonsillar abscess: While CT is standard, growing interest in bedside ultrasound for initial differentiation of cellulitis from abscess and guiding aspiration, potentially reducing radiation exposure.
  • Management of recurrent peritonsillar abscess: Debate exists regarding the necessity of tonsillectomy after a single episode vs. recurrent episodes.
  • Antibiotic stewardship: Ongoing efforts to reduce inappropriate antibiotic prescribing for viral pharyngitis remain a focus due to concerns about resistance.

Key References

• Guidelines:
  • Shulman ST, Bisno AL, Clegg HW, et al. Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55(10):e86-e102.
  • Mitchell RB, Archer SM, Ishman SM, et al. Clinical Practice Guideline: Tonsillectomy in Children (Update). Otolaryngol Head Neck Surg. 2019;160(1_suppl):S1-S42.
• Studies:
  • Paradise JL, Bluestone CD, Bachman RZ, et al. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of a randomized controlled clinical trial. N Engl J Med. 1984;310(11):674-683. (Landmark study for recurrent tonsillitis criteria).
  • Goldstein NA, Goldman J, Bhattacharyya N, et al. Tonsillectomy and Adenoidectomy for Obstructive Sleep Apnea in Children: A Systematic Review. Otolaryngol Head Neck Surg. 2021;165(3):398-410.
• Reviews:
  • Bisno AL. Acute Pharyngitis. N Engl J Med. 2001;344(3):205-211.
  • Centor RM, Witherspoon JM, Dalton HP, et al. The efficacy of clinical criteria in the diagnosis of streptococcal pharyngitis. Ann Intern Med. 1981;95(5):505-507.